F, P., V, P., G, D., R, M., I, P., F, R., . . . M, Z. (2026). Antiplatelet Therapy and All-Cause Mortality After Transcatheter Aortic Valve Replacement: The TRITAVI Registry. JACC. Advances, 5(5), 102772. https://doi.org/10.1016/j.jacadv.2026.102772
Chicago Style (17th ed.) CitationF, Pelliccia, et al. "Antiplatelet Therapy and All-Cause Mortality After Transcatheter Aortic Valve Replacement: The TRITAVI Registry." JACC. Advances 5, no. 5 (2026): 102772. https://doi.org/10.1016/j.jacadv.2026.102772.
MLA (9th ed.) CitationF, Pelliccia, et al. "Antiplatelet Therapy and All-Cause Mortality After Transcatheter Aortic Valve Replacement: The TRITAVI Registry." JACC. Advances, vol. 5, no. 5, 2026, p. 102772, https://doi.org/10.1016/j.jacadv.2026.102772.